BioSpace News Archive

Certara®, the global model-informed drug development and decision support leader, today announced that its Simcyp® Population-based Simulator was used to support Galderma’s successful U.S. Food and Drug Administration (FDA) new drug application (NDA) for AKLIEF (trifarotene) Cream, 0.005%

Agreement enabled by Veracyte acquisition of NanoString diagnostics assets for global expansion

Positive correlation seen between the Cunningham Panel assay results and patients’ neuropsychiatric symptoms

The conference will take place January 13-16, 2020, at the Westin St. Francis Hotel in San Francisco.

Potential First-in-Class Therapy for Chronic Spinal Cord Injury

ViaCyte, Inc., a privately-held regenerative medicine company, announced that ViaCyte’s President and CEO Paul Laikind, Ph.D. will present at Biotech Showcase™ 2020, to be held January 13 to 15 at the Hilton San Francisco Union Square..

SyntheticMR announced today at the American Society of Pediatric Neuroradiology (ASPNR) the clinical use of their novel MR quantification solution, SyMRI, at Cincinnati Children’s Hospital Medical Center, for pediatric cases requiring cerebrospinal fluid measurements - and, for the first time, whole-brain myelin.

Investment enables expansion of Komodo’s end-to-end analytics platform and products built atop the most complete healthcare dataset

Multifactorial liver and systemic biological activity seen for both AXA1125 and AXA1957 in adult subjects with NAFLD at 16 weeks with onset as early as eight weeks

Tarveda Therapeutics, Inc. announced that Drew Fromkin, President and Chief Executive Officer, will present at the 2020 Biotech Showcase, occurring January 13-15, 2020 at the Hilton Union Square in San Francisco, CA.